Literature DB >> 20024699

Availability of HIV-related health services in adolescent substance abuse treatment programs.

H K Knudsen1, C B Oser.   

Abstract

Given that alcohol and drug abuse heightens the risk of adolescents acquiring HIV, substance abuse treatment programs for youths may represent an important site of HIV prevention. In this research, we explored the adoption of three HIV-related health services: risk assessment during intake, HIV prevention programing, and HIV testing. Data were collection through telephone interviews with 149 managers of adolescent-only substance abuse treatment programs in the USA. About half of these programs had adopted HIV risk assessment and HIV prevention. On-site HIV testing was less widely adopted, with only one in four programs offering this service. At the bivariate level, the availability of on-site primary medical care and the availability of an overnight level of care were positively associated with these three types of services. The association for the measure of an overnight level of care was no longer significant once medical services were controlled. However, in a separate analysis, it was found that programs offering an overnight level of care were much more likely to offer on-site medical care than outpatient-only facilities. There was also evidence that publicly funded treatment programs were more likely to offer HIV prevention and on-site HIV testing, after controlling for other organizational characteristics. Much more research about the adoption of HIV-related services in adolescent substance abuse treatment is needed, particularly to offer greater insight into why certain types of organizations are more likely to adopt these health services.

Entities:  

Mesh:

Year:  2009        PMID: 20024699      PMCID: PMC3857723          DOI: 10.1080/09540120902803182

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  40 in total

1.  Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization?

Authors:  P D Friedmann; T A D'Aunno; L Jin; J A Alexander
Journal:  Health Serv Res       Date:  2000-06       Impact factor: 3.402

2.  Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs.

Authors:  M L Prendergast; D Urada; D Podus
Journal:  J Consult Clin Psychol       Date:  2001-06

3.  Expanding the range of interventions to reduce HIV among adolescents.

Authors:  M J Rotheram-Borus
Journal:  AIDS       Date:  2000-06       Impact factor: 4.177

4.  Characteristics and problems of 600 adolescent cannabis abusers in outpatient treatment.

Authors:  Frank M Tims; Michael L Dennis; Nancy Hamilton; Betty J Buchan; Guy Diamond; Rod Funk; Laura B Brantley
Journal:  Addiction       Date:  2002-12       Impact factor: 6.526

5.  Reducing STD and HIV risk behavior of substance-dependent adolescents: a randomized controlled trial.

Authors:  Janet S St Lawrence; Richard A Crosby; Ted L Brasfield; Robert E O'Bannon
Journal:  J Consult Clin Psychol       Date:  2002-08

6.  An evaluation of drug treatments for adolescents in 4 US cities.

Authors:  Y I Hser; C E Grella; R L Hubbard; S C Hsieh; B W Fletcher; B S Brown; M D Anglin
Journal:  Arch Gen Psychiatry       Date:  2001-07

Review 7.  Drug abuse treatment as an HIV prevention strategy: a review.

Authors:  J L Sorensen; A L Copeland
Journal:  Drug Alcohol Depend       Date:  2000-04-01       Impact factor: 4.492

8.  Characterizing substance abuse programs that treat adolescents.

Authors:  Tami L Mark; Xue Song; Rita Vandivort; Sarah Duffy; Jutta Butler; Rosanna Coffey; Vernon F Schabert
Journal:  J Subst Abuse Treat       Date:  2006-07

9.  Substance-abusing adolescents at varying levels of HIV risk: psychosocial characteristics, drug use, and sexual behavior.

Authors:  R M Malow; J G Dévieux; T Jennings; B A Lucenko; S C Kalichman
Journal:  J Subst Abuse       Date:  2001

10.  On-site HIV testing in residential drug treatment units: results of a nationwide survey.

Authors:  Shiela M Strauss; Don C Des Jarlais; Janetta Astone; Zdravko P Vassilev
Journal:  Public Health Rep       Date:  2003 Jan-Feb       Impact factor: 2.792

View more
  11 in total

1.  Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs.

Authors:  Amanda J Abraham; Lauren A O'Brien; Hannah K Knudsen; Brian E Bride; G Rush Smith; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2012-04-25

2.  Provision of onsite HIV Services in Substance Use Disorder Treatment Programs: A Longitudinal Analysis.

Authors:  Lydia Aletraris; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2015-04-13

Review 3.  Drug treatment as HIV prevention: a research update.

Authors:  David S Metzger; George E Woody; Charles P O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

4.  Prevalence and correlates of HIV risk among adolescents and young adults reporting drug use: Data from an urban Emergency Department in the U.S.

Authors:  Erin E Bonar; Lauren K Whiteside; Maureen A Walton; Marc A Zimmerman; Brenda M Booth; Frederic C Blow; Rebecca Cunningham
Journal:  J HIV AIDS Soc Serv       Date:  2014-06-01

5.  HIV rapid testing in drug treatment: comparison across treatment modalities.

Authors:  Robert P Schwartz; Maxine L Stitzer; Daniel J Feaster; P Todd Korthuis; Anika A H Alvanzo; Theresa M Winhusen; Lillian Donnard; Ned Snead; Lisa R Metsch
Journal:  J Subst Abuse Treat       Date:  2012-09-27

6.  HIV testing in recent college students: prevalence and correlates.

Authors:  Kimberly M Caldeira; Barbara J Singer; Kevin E O'Grady; Kathryn B Vincent; Amelia M Arria
Journal:  AIDS Educ Prev       Date:  2012-08

7.  HIV/AIDS services in private substance abuse treatment programs.

Authors:  Amanda J Abraham; Lauren A O'Brien; Brian E Bride; Paul M Roman
Journal:  Drug Alcohol Depend       Date:  2010-12-08       Impact factor: 4.492

8.  Prevalence and predictors of injection drug use and risky sexual behaviors among adolescents in substance treatment.

Authors:  Christian Thurstone; Stacy Salomonsen-Sautel; Susan K Mikulich-Gilbertson; Christie A Hartman; Joseph T Sakai; Analice S Hoffenberg; Matt B McQueen; Sung-Joon Min; Thomas J Crowley; Robin P Corley; John K Hewitt; Christian J Hopfer
Journal:  Am J Addict       Date:  2013-08-31

9.  Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users.

Authors:  Lauren E Cipriano; Gregory S Zaric; Mark Holodniy; Eran Bendavid; Douglas K Owens; Margaret L Brandeau
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

10.  Nonmedical prescription drug users in private vs. public substance abuse treatment: a cross sectional comparison of demographic and HIV risk behavior profiles.

Authors:  Catherine L O'Grady; Hilary L Surratt; Steven P Kurtz; Maria A Levi-Minzi
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.